SG11201907400YA - Method for treating myopia and application in preparation of medicament - Google Patents

Method for treating myopia and application in preparation of medicament

Info

Publication number
SG11201907400YA
SG11201907400YA SG11201907400YA SG11201907400YA SG11201907400YA SG 11201907400Y A SG11201907400Y A SG 11201907400YA SG 11201907400Y A SG11201907400Y A SG 11201907400YA SG 11201907400Y A SG11201907400Y A SG 11201907400YA SG 11201907400Y A SG11201907400Y A SG 11201907400YA
Authority
SG
Singapore
Prior art keywords
medicament
preparation
application
treating myopia
myopia
Prior art date
Application number
SG11201907400YA
Other languages
English (en)
Inventor
Xiangtian Zhou
Sen Zhang
Jia Qu
Guoyun Zhang
Fei Zhao
Xuan Zhou
Original Assignee
Univ Wenzhou Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wenzhou Medical filed Critical Univ Wenzhou Medical
Publication of SG11201907400YA publication Critical patent/SG11201907400YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488—Pueraria (kudzu)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
SG11201907400YA 2018-07-18 2019-03-22 Method for treating myopia and application in preparation of medicament SG11201907400YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201810787541 2018-07-18
PCT/CN2019/079184 WO2020015377A1 (zh) 2018-07-18 2019-03-22 一种治疗近视的方法及制备药物的应用

Publications (1)

Publication Number Publication Date
SG11201907400YA true SG11201907400YA (en) 2020-02-27

Family

ID=69163863

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201907400YA SG11201907400YA (en) 2018-07-18 2019-03-22 Method for treating myopia and application in preparation of medicament

Country Status (6)

Country Link
US (1) US20220016023A1 (ja)
EP (1) EP3616723A4 (ja)
JP (1) JP7039606B2 (ja)
CN (1) CN110933933B (ja)
SG (1) SG11201907400YA (ja)
WO (1) WO2020015377A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024048750A1 (ja) * 2022-08-31 2024-03-07 株式会社坪田ラボ α１ブロッカーを含む近視進行抑制用点眼剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1128656A (zh) * 1995-10-04 1996-08-14 姚作玉 山莨菪碱在制备治疗近视眼药水中的应用
WO2000054773A1 (en) * 1999-03-12 2000-09-21 Nitromed, Inc. Dopamine agonists in combination with nitric oxide donors, compositions and methods of use
AU2000275035A1 (en) * 2000-09-20 2002-04-02 Yong Guang Pharmaceutical Co., Ltd. Therapeutic and prophylactic drugs of myopia
CN1132584C (zh) * 2001-02-19 2003-12-31 尹卫平 一种治疗近视的滴眼剂
CN1231226C (zh) * 2002-11-18 2005-12-14 张淑清 一种治疗近视、远视、斜视及弱视的复合制剂
CN1878569A (zh) * 2003-09-12 2006-12-13 阿勒根公司 用于治疗疼痛和其它α2肾上腺素能介导疾病的方法及组合物
US20060264442A1 (en) * 2005-05-18 2006-11-23 Allergan, Inc. Methods for the treatment of ocular and neurodegenerative conditions in a mammal
EP2042179A1 (en) * 2007-09-26 2009-04-01 sanofi-aventis Novel therapeutic uses of adrenergic alpha-1 receptor antagonists
CN102552091A (zh) * 2012-02-08 2012-07-11 梁杰 具有促进睫毛生长作用的眼线液
RU2635185C2 (ru) * 2013-12-17 2017-11-09 Иван Дмитриевич Захаров Фармацевтический препарат для профилактики и лечения прогрессирующей близорукости
DK3193867T3 (da) * 2014-09-17 2021-04-06 Panoptica Inc Okulære formuleringer til lægemiddelfremføring og beskyttelse af øjets forreste segment
JP6784407B2 (ja) * 2015-04-24 2020-11-11 学校法人慶應義塾 近視予防剤及び近視進行抑制剤
CN107320725B (zh) * 2017-06-29 2020-10-09 温州医科大学 一种抑制近视的方法及制备药物的应用
CN111093648A (zh) * 2017-07-20 2020-05-01 艾伦实验室股份有限公司 治疗近视的组合物和方法
US20210128523A1 (en) * 2017-08-25 2021-05-06 Sulfateq B.V. Medicaments for the treatment of vasoconstriction related diseases or disorders

Also Published As

Publication number Publication date
CN110933933A (zh) 2020-03-27
US20220016023A1 (en) 2022-01-20
EP3616723A4 (en) 2020-03-25
JP2020529965A (ja) 2020-10-15
JP7039606B2 (ja) 2022-03-22
EP3616723A1 (en) 2020-03-04
CN110933933B (zh) 2022-12-27
WO2020015377A1 (zh) 2020-01-23

Similar Documents

Publication Publication Date Title
IL261884B (en) Compounds of natural extracts, and their use in methods to prevent or treat diseases
IL268327A (en) A pharmaceutical preparation for use in the treatment and prevention of c5-related diseases and methods for the treatment and prevention of c5-related diseases
EP3681479A4 (en) METHOD OF ADMINISTRATION AND TREATMENT
IL279748A (en) Preparation and method for treating pain
IL253703B (en) A device for treating blood vessels in the skin
IL280475A (en) A pharmaceutical composition for use in the treatment or prevention of a C5-related disease and a method for the treatment or prevention of a C5-related disease
HK1253320A1 (zh) 用於治療aml的藥物組合物和治療有此需要的對象中的aml的方法
EP3554310A4 (en) PACKAGED SKIN TREATMENT COMPOSITION AND METHOD
IL264407A (en) Administration of gzd824 and salts are accepted in the treatment of diseases
EP3713583A4 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF THE SKIN
IL277201A (en) Device and method for treating dry eyes
IL272121A (en) Preparation and methods for the treatment of myopia
EP3618923A4 (en) SYSTEM AND METHOD FOR TREATING MYOPIA
HK1243635A1 (zh) 治療皮膚病況的組合物和方法
EP3643324A4 (en) METHOD OF INHIBITING MYOPIA AND APPLICATION IN THE PREPARATION OF A MEDICINAL PRODUCT
EP3849591A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES
EP3576658A4 (en) APPARATUS WITH FILTER FOR TREATING MACULAR DEGENERATION AND METHOD FOR TREATING MACULAR DEGENERATION
SG11201907400YA (en) Method for treating myopia and application in preparation of medicament
IL271727A (en) Method of treatment and their dosage forms
EP3342417A4 (en) COMPOSITION FOR BODY SLIMMING AND SKIN CARE AND PREPARATION METHOD THEREOF
EP3727393A4 (en) METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING CANDIDA AURIS IN BLOOD
GB201810923D0 (en) Compositions and method of treatment
EP3423102A4 (en) PROCESS FOR THE EXTRACORPOREAL TREATMENT OF PRECLAMPSIA AND RELATED DISORDERS
EP4025234A4 (en) METHOD AND USE OF PNPP-19 FOR PREVENTING AND TREATING EYE DISEASES
ZA201802772B (en) Hair treatment composition and method